Research output per year
Research output per year
Personal profile
Academic discipline
MEDS-05/A - Internal Medicine
Fingerprint
Dive into the research topics where Daniela Pugliese is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
Research output
- 96 Article
-
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium Net
Murgiano, M., Balestrieri, P., Calabrese, E., Fiorino, G., Festa, S., Pugliese, D., Di Vincenzo, F., Puca, P., Parello, S., Vespasiano, V., Colella, A., Marafini, I., Profeta, F., Foscarini, E., Papa, A., Lopetuso, L. R., Monteleone, G., Cicala, M., Gasbarrini, A. & Laterza, L. & 1 others, , 2026, In: BMJ Open Gastroenterology. 13, 1, p. N/A-N/AResearch output: Contribution to journal › Article
-
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology
Scaldaferri, F., Di Vincenzo, F., Falco, G. M., Lazzaro, F. G., Aloi, M., Alivernini, S., Scolieri, P., Balestrieri, P., Basile, M., Cela, E., Bianchi, L., Biancone, L., Bosello, S. L., Calabrese, E., Caldarola, G., Cammarota, G., Capacci, A., Chimenti, M. S., Cicala, M. & Cicchetti, A. & 40 others, , 2026, In: Digestive and Liver Disease. N/A, p. N/A-N/AResearch output: Contribution to journal › Article
-
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study
Scaldaferri, F., Di Vincenzo, F., Aloi, M., Ascolani, M., Balestrieri, P., Bertani, L., Bezzio, C., Bodini, G., Bossa, F., Calabrese, E., Cannatelli, R., Caprioli, F., Cappello, M., Cicala, M., D'Amico, F., Danese, S., De Bernardi, A., De Filippo, F. R., Desideri, F. & Di Paolo, D. & 36 others, , 2026, In: THE AMERICAN JOURNAL OF GASTROENTEROLOGY. Publish Ahead of Print, Feb, p. N/A-N/AResearch output: Contribution to journal › Article
-
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting
Del Gaudio, A., Di Vincenzo, F., Cuccia, G., Coppola, G., Laterza, L., Sacchetti, F., Caprino, P., Sofo, L., Dragoni, G., Foscarini, E., Profeta, F., Schiavoni, E., Napolitano, D., Gasbarrini, A., Pugliese, D., Papa, A., Lopetuso, L. R. & Scaldaferri, F., 2026, In: Inflammatory Bowel Diseases. N/A, p. N/A-N/AResearch output: Contribution to journal › Article
-
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net study
Del Gaudio, A., Calabrese, E., Balestrieri, P., Pugliese, D., Fiorino, G., Di Vincenzo, F., Marafini, I., Baldaro, F., Cuccia, G., Cascella, F., Colella, A., Parisio, L., Murgiano, M., Laterza, L., Gasbarrini, A., Papa, A., Lopetuso, L. R. & Scaldaferri, F., 2026, In: Digestive and Liver Disease. 58, 8, p. 1037-1042 6 p.Research output: Contribution to journal › Article
Datasets
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497.v1, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497/1
Dataset
-
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
Guidi, L. (Creator), Pugliese, D. (Creator), Tonucci, T. P. (Creator), Bertani, L. (Creator), Costa, F. (Creator), Privitera, G. (Creator), Tolusso, B. (Creator), Di Mario, C. (Contributor), Albano, E. (Creator), Tapete, G. (Creator), Gremese, E. (Creator), Papa, A. (Creator), Gasbarrini, A. (Creator), Rapaccini, G. L. (Creator) & Armuzzi, A. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4653497.v1, https://sage.figshare.com/collections/Early_vedolizumab_trough_levels_predict_treatment_persistence_over_the_first_year_in_inflammatory_bowel_disease/4653497/1
Dataset
-
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Tursi, A. (Creator), Mocci, G. (Creator), Scaldaferri, F. (Creator), Napolitano, D. (Creator), Maresca, R. (Creator), Pugliese, D. (Creator), Semprucci, G. (Creator), Savarino, E. (Creator), Cuomo, A. (Creator), Donnarumma, L. (Creator), Bodini, G. (Creator), Pasta, A. (Creator), Maconi, G. (Creator), Cataletti, G. (Creator), Pranzo, G. (Creator), Rodinò, S. (Creator), Sebkova, L. (Creator), Costa, F. (Creator), Ferronato, A. (Creator), Gaiani, F. (Creator), Marzo, M. (Creator), Luppino, I. (Creator), Fabiano, G. (Creator), Paese, P. (Creator), Elisei, W. (Creator), Monterubbianesi, R. (Creator), Faggiani, R. (Creator), Grossi, L. (Creator), Serio, M. (Creator), Scarcelli, A. (Creator), Lorenzetti, R. (Creator), Allegretta, L. (Creator), Chiri, S. (Creator), Grasso, G. (Creator), Antonelli, E. (Creator), Bassotti, G. (Creator), Spagnuolo, R. (Creator), Luzza, F. (Creator), Fanigliulo, L. (Creator), Rocco, G. (Creator), Sacchi, C. (Creator), Zampaletta, C. (Creator), Rocchi, C. (Creator), Bolognini, L. (Creator), Bendia, E. (Creator), Bianco, M. A. (Creator), Capone, P. (Creator), Meucci, C. (Creator), Colucci, R. (Creator), Tonti, P. (Creator), Neve, V. (Creator), Della Valle, N. (Creator), Felice, C. (Creator), Pica, R. (Creator), Cocco, A. (Creator), Forti, G. (Creator), Onidi, F. M. (Creator), Usai Satta, P. (Contributor), Checchin, D. (Creator), Gravina, A. G. (Creator), Pellegrino, R. (Creator), Picchio, M. (Creator) & Papa, A. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.25039971, https://tandf.figshare.com/articles/dataset/Ustekinumab_safety_and_effectiveness_in_patients_with_ulcerative_colitis_results_from_a_large_real-life_study/25039971
Dataset
-
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Tursi, A. (Creator), Mocci, G. (Creator), Scaldaferri, F. (Creator), Napolitano, D. (Creator), Maresca, R. (Creator), Pugliese, D. (Creator), Semprucci, G. (Creator), Savarino, E. (Creator), Cuomo, A. (Creator), Donnarumma, L. (Creator), Bodini, G. (Creator), Pasta, A. (Creator), Maconi, G. (Creator), Cataletti, G. (Creator), Pranzo, G. (Creator), Rodinò, S. (Creator), Sebkova, L. (Creator), Costa, F. (Creator), Ferronato, A. (Creator), Gaiani, F. (Creator), Marzo, M. (Creator), Luppino, I. (Creator), Fabiano, G. (Creator), Paese, P. (Creator), Elisei, W. (Creator), Monterubbianesi, R. (Creator), Faggiani, R. (Creator), Grossi, L. (Creator), Serio, M. (Creator), Scarcelli, A. (Creator), Lorenzetti, R. (Creator), Allegretta, L. (Creator), Chiri, S. (Creator), Grasso, G. (Creator), Antonelli, E. (Creator), Bassotti, G. (Creator), Spagnuolo, R. (Creator), Luzza, F. (Creator), Fanigliulo, L. (Creator), Rocco, G. (Creator), Sacchi, C. (Creator), Zampaletta, C. (Creator), Rocchi, C. (Creator), Bolognini, L. (Creator), Bendia, E. (Creator), Bianco, M. A. (Creator), Capone, P. (Creator), Meucci, C. (Creator), Colucci, R. (Creator), Tonti, P. (Creator), Neve, V. (Creator), Della Valle, N. (Creator), Felice, C. (Creator), Pica, R. (Creator), Cocco, A. (Creator), Forti, G. (Creator), Onidi, F. M. (Creator), Usai Satta, P. (Contributor), Checchin, D. (Creator), Gravina, A. G. (Creator), Pellegrino, R. (Creator), Picchio, M. (Creator) & Papa, A. (Creator), Taylor & Francis, 2024
DOI: 10.6084/m9.figshare.25039971.v1, https://tandf.figshare.com/articles/dataset/Ustekinumab_safety_and_effectiveness_in_patients_with_ulcerative_colitis_results_from_a_large_real-life_study/25039971/1
Dataset